INSIGHT MOLECULAR DIAGNOSTIC
IMDXNASDAQ🏆 #3484 by market capEarnings Nov 5US Equity
$4.25▼ $0.17 (−4.06%)
Live1h▼ 0.5%
24h▼ 4.1%
7d▼ 14.8%
14d▼ 3.0%
30d▼ 9.0%
1y▲ 73.5%
🏦Market Cap
$137M
Small Cap
📈Revenue Growth (YoY)
-49.3%
Declining
📊Gross Margin
51.3%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
80.8x
Expensive
Otter Score
54
Weak
📊
Analyst Ratings
Price
$4.25
Total
11
Raised
0
Lowered
2
Avg PT
$12.00
H / L
$12 / $12
| Institution | Action | Rating | Date |
|---|---|---|---|
Lake Street | Reiterated | Buy | 2026-02-17 |
Needham | Reiterated | Buy | 2025-11-11 |
Stephens & Co. | Reiterated | Equal Weight | 2025-03-26 |
Benchmark | Reiterated | Speculative Buy | 2023-08-23 |
Piper Sandler | Reiterated | Neutral | 2023-08-14 |
Keybanc | Downgraded | Overweight → Sector Weight | 2022-03-14 |
BTIG | Reiterated | Buy | 2020-11-30 |
KeyBanc | Reiterated | Overweight | 2020-11-10 |
Chardan Capital | Downgraded | Buy → Neutral | 2020-06-30 |
PiperJaffray | Reiterated | Overweight | 2019-02-13 |
Janney Capital | Reiterated | Buy | 2016-03-15 |
One row per institution, most recent rating